The National Financial Regulatory Administration (NFRA) has issued a notice to the insurance industry, reinforcing policies that encourage the long-term investment of capital.
The National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and Social Security (MoHRSS) have jointly issued China's first-ever innovative drug catalogue designed specifically for commercial health insurance. One objective is to unlock new growth opportunities for the commercial health insurance market.
Traditional asset allocation strategies must change in the current market environment, according to the Vice President and Chief Investment Officer of China Pacific Insurance (CPIC), Mr Su Gang.
The growth rates of health insurance business in China have diverged significantly between life insurers and property & casualty (P&C) insurers.
Four out of seven standalone health insurers in China recorded a combined CNY60.07bn ($8.5bn) in premium income in the first half of 2025, with net profits of CNY6.6bn, according to the "China Insurance Industry Competitiveness Research Report (2025)".
One of China's biggest insurance companies, New China Insurance (NCI), is planning to raise up to CNY10bn ($1.4bn) via the issuance of domestic undated capital bonds. The funds raised are to strengthen the company's capital base and enhance its solvency adequacy ratios.
While European Union companies remain committed to the Chinese market, China's outsized influence on supply chains is now resulting in negative outcomes for some foreign companies and third-country markets alike, which is pushing them to diversify away from the country in certain areas, says the European Chamber (EC) in China in a statement.
The Economic Investigation Unit of the Municipal Public Security Bureau of Nantong City in Jiangsu Province received a report in February 2023 that a metal products manufacturer had experienced an unusually high frequency of insurance incidents for at least three years in a row and was suspected of committing insurance fraud. This led to the uncovering of a massive insurance fraud case spanning nine provinces and involving CNY270m ($38.2m).
The universal life insurance market is projected to register a compound annual growth rate (CAGR) of 8.1% from 2024 to 2033, according to Allied Market Research.
China Reinsurance (China Re) has announced that Ms Zhu Xiaoyun, the company's Executive Director and Vice President, has been appointed as Deputy Secretary of the Party Committee and proposed President.